 |
 |
|
|
RESÚMENES DICIEMBRE 2005 |
Addictive Disorders
(Haga un click en la información del journal para acceder al
resúmen)
Dorothy K.
Hatsukami, Stephen Rennard, Douglas Jorenby, Michael Fiore, Joseph Koopmeiners,
Arjen de Vos, Gary Horwith and Paul R. Pentel
Clinical
Pharmacology & Therapeutics. Volume 78, Issue 5, November 2005, Pages
456-467
M. G. Bossong, J.
P. Van Dijk, R. J. M. Niesink
Addiction Biology. Volume 10, Number 4 / December
2005: 321 - 323
Shannon C. Miller
Addiction Biology. Volume 10, Number 4 / December
2005: 325 - 327
Protective effect of cyclooxygenase-2 (COX-2) inhibitors but not non-selective cyclooxygenase (COX)-inhibitors on ethanol withdrawal-induced behavioural changes
Ashish Dhir,
Pattipati S. Naidu, Shrinivas K. Kulkarni
Addiction Biology. Volume 10, Number 4 / December
2005: 329 - 335
Smoking reduction treatment with 4-mg nicotine gum: A
double-blind, randomized, placebo-controlled study
Anil Batra, Karl
Klingler, Björn Landfeldt, Hubertus M. Friederich, Åke Westin and Tobias
Danielsson
Clinical
Pharmacology & Therapeutics. Volume 78, Issue 6, December 2005, Pages
689-696
Role of Functional Genetic Variation in the Dopamine D2
Receptor (DRD2) in Response to Bupropion and Nicotine Replacement Therapy for
Tobacco Dependence: Results of Two Randomized Clinical Trials
Caryn Lerman, Christopher Jepson,
E Paul Wileyto, Leonard H Epstein, Margaret Rukstalis, Freda Patterson, Vyga
Kaufmann, Stephanie Restine, Larry Hawk, Ray Niaura and Wade Berrettini
Neuropsychopharmacology (2006) 31, 231-242
Alcoholism and suicidal behavior: a clinical
overview
Sher L
Acta Psychiatr Scand 2005: 1–10
Differential protein expression in the
prefrontal white matter of human alcoholics: a proteomics study
K Alexander-Kaufman, G James, D Sheedy, C Harper and I Matsumoto
Molecular Psychiatry (2006) 11, 56–65
Traci L. Steuber
and Fred Danner
Addictive
Behaviors. Volume 31, Issue 1, January 2006, Pages 133-136
Kevin D. McCaul,
Jill R. Hockemeyer, Rebecca J. Johnson, Kimberlee Zetocha, Kathryn Quinlan and
Russell E. Glasgow
Addictive
Behaviors. Volume 31, Issue 1, January 2006, Pages 42-56
Adolescent alcohol use is a risk factor for adult alcohol
and drug dependence: evidence from a twin design
JULIA
D. GRANT, JEFFREY F. SCHERRER, MICHAEL T. LYNSKEY, MICHAEL
J. LYONS, SETH A. EISEN, MING T. TSUANG, WILLIAM R. TRUE
and KATHLEEN K. BUCHOLZ
Psychological Medicine (2006), 36: 109-118
Combined Effects of Venlafaxine, Nicotine Replacement, and
Brief Counseling on Smoking Cessation
Paul M.
Cinciripini, Janice Y. Tsoh, David W. Wetter, Cho Lam, Carl de Moor, Lynn
Cinciripini, Walter Baile, Cheryl Anderson and John D. Minna
Experimental
and Clinical Psychopharmacology. Volume 13, Issue 4, November 2005, Pages
282-292
Predictors of Outcome in LAAM, Buprenorphine, and Methadone
Treatment for Opioid Dependence
Lisa A. Marsch,
Mary Ann Chutuape Stephens, Timothy Mudric, Eric C. Strain, George E. Bigelow
and Rolley E. Johnson
Experimental
and Clinical Psychopharmacology. Volume 13, Issue 4, November 2005, Pages
293-302
Opioid antagonist detoxification under anaesthesia versus
traditional clonidine detoxification combined with an additional week of
psychosocial support: A randomised clinical trial
B. Favrat, G.
Zimmermann, D. Zullino, S. Krenz, F. Dorogy, J. Muller, A. Zwahlen, B. Broers
and J. Besson
Drug and Alcohol Dependence. Volume 81, Issue 2, 1
February 2006, Pages 109-116
Treatment of methadone-maintained patients with adult ADHD:
Double-blind comparison of methylphenidate, bupropion and placebo
Frances R. Levin,
Suzette M. Evans, Daniel J. Brooks, Aparna S. Kalbag, Fatima Garawi and Edward
V. Nunes
Drug and Alcohol Dependence. Volume 81, Issue 2, 1
February 2006, Pages 137-148
The mesolimbic dopamine system: The final common pathway for
the reinforcing effect of drugs of abuse?
R. Christopher
Pierce and Vidhya Kumaresan